Aghion Daniel bought ORMP
January 30, 2024 · Form 4 insider transaction
Aghion Daniel bought 3,750 shares of Oramed Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,750
Price
N/A
Total value
N/A
InsiderAghion Daniel
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2024
Filing dateJanuary 30, 2024
Shares owned after38,820
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 937 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.